疾病信息 API

疾病信息 API API ID: 4424

提供有关疾病的准确细节，包括与每种医学情况相关的基因、遗传变异和表型
通过 MCP 从您的 AI 代理使用此 API
支持 OpenClaw、Claude Code/Desktop、Cursor、Windsurf、Cline 以及任何兼容 MCP 的 AI 客户端。
文档和设置
通过封装此 MCP 创建技能： https://mcp.zylalabs.com/mcp?apikey=YOUR_ZYLA_API_KEY

关于API：  

该API提供广泛的详细疾病信息，便于获取医学分析和应用所需的关键信息。从特定相关基因到遗传变异和相关表型，API成为理解和解决各种医学问题的宝贵工具

在其核心，API提供对全面疾病数据的访问，能够查询与特定疾病相关的基因、与该病症相关的遗传变异以及相关的临床表型。这些信息对研究疾病遗传基础的研究人员至关重要，因为它提供了关于某些基因及其变异如何影响特定疾病的易感性或发展过程的详细见解

该API的亮点在于其能够与现有医疗和生物医学研究的应用程序及系统轻松集成。这使得开发人员能够创建自定义工具，利用API数据改善复杂疾病的诊断、治疗和理解

简而言之，该API不仅提供详细和准确的疾病、基因和遗传变异数据的访问，还因其支持科学研究、医学创新和基于证据的医疗保健的持续改进而脱颖而出。它的多样性和稳健性使其成为任何寻求从先进基因组和临床角度理解和应对疾病复杂性的从业者或研究人员的重要工具

 

此API接收什么以及您的API提供什么（输入/输出）？

它将接收一个参数并为您提供一个JSON

 

此API最常见的使用案例是什么？

  1. 遗传研究：通过提供与疾病相关的基因和遗传变异的全面数据，促进对疾病遗传基础的研究

    临床决策支持系统：整合疾病信息以增强临床决策，帮助医疗专业人员进行诊断和治疗规划

    药物开发：通过提供基于遗传和临床数据的疾病机制和潜在治疗靶点的见解，支持制药公司

    个性化医疗：基于遗传特征和疾病易感性制定个性化治疗计划，以改善患者结果

    流行病学研究：协助研究人员研究疾病的流行情况、遗传易感性和影响疾病传播及严重性的环境因素

     

您的计划是否有任何限制？

除了API调用次数外，没有其他限制

API 文档

端点

要使用此端点，您必须在参数中指明疾病的名称



                                                                            
GET https://pr140-testing.zylalabs.com/api/4424/diseases+information+api/5437/disease

疾病 - 端点功能

对象 描述
q [必需]
测试端点

API 示例响应

       
                                                                                                        
                                                                                                                                                                                                                                                                                                                                        {"took":16,"total":724,"max_score":7.9725885,"hits":[{"_id":"MONDO:0011361","_score":7.9725885,"ctd":{"omim":"603688","pathway_related_to_disease":[{"inference_gene_symbol":"EPHB2","kegg_pathway_id":"hsa04360","pathway_name":"Axon guidance","source":"CTD"},{"inference_gene_symbol":"EPHB2","pathway_name":"Developmental Biology","react_pathway_id":"R-HSA-1266738","source":"CTD"},{"inference_gene_symbol":"EPHB2","pathway_name":"EPH-Ephrin signaling","react_pathway_id":"R-HSA-2682334","source":"CTD"},{"inference_gene_symbol":"EPHB2","pathway_name":"L1CAM interactions","react_pathway_id":"R-HSA-373760","source":"CTD"},{"inference_gene_symbol":"EPHB2","pathway_name":"EPHB-mediated forward signaling","react_pathway_id":"R-HSA-3928662","source":"CTD"},{"inference_gene_symbol":"EPHB2","pathway_name":"Ephrin signaling","react_pathway_id":"R-HSA-3928664","source":"CTD"},{"inference_gene_symbol":"EPHB2","pathway_name":"EPH-ephrin mediated repulsion of cells","react_pathway_id":"R-HSA-3928665","source":"CTD"},{"inference_gene_symbol":"EPHB2","pathway_name":"Axon guidance","react_pathway_id":"R-HSA-422475","source":"CTD"}]},"disgenet":{"_license":"https://creativecommons.org/licenses/by/4.0/","genes_related_to_disease":[{"DPI":0.846,"DSI":0.374,"gene_id":2048,"gene_name":"EPHB2","score":0.4,"source":"CLINVAR"},{"DPI":0.846,"DSI":0.374,"gene_id":2048,"gene_name":"EPHB2","score":0.4,"source":"CTD_human"}],"variants_related_to_disease":[{"DSI":1.0,"chrom":"1","pos":22907980,"rsid":"rs121912582","score":0.7,"source":"CLINVAR"},{"DPI":0.08,"DSI":0.882,"chrom":"1","pos":22913757,"rsid":"rs76826147","score":0.7,"source":"CLINVAR"}],"xrefs":{"disease_name":"PROSTATE CANCER/BRAIN CANCER SUSCEPTIBILITY (finding)","mondo":"MONDO:0011361","omim":"603688","umls":"C1863600"}},"hpo":{"disease_name":"Prostate cancer/brain cancer susceptibility","omim":"603688","phenotype_related_to_disease":[{"biocuration":{"date":"2013-01-14","name":"HPO:skoehler"},"evidence":"IEA","hpo_id":"HP:0100006","omim_refs":"OMIM:603688","original_disease_id":"OMIM:603688"},{"biocuration":{"date":"2013-01-09","name":"HPO:skoehler"},"evidence":"IEA","hpo_id":"HP:0012125","omim_refs":"OMIM:603688","original_disease_id":"OMIM:603688"}]},"mondo":{"ancestors":["MONDO:0003847","MONDO:0020573","MONDO:0023370","MONDO:0021058","MONDO:0700096","MONDO:0002254","MONDO:0045024","MONDO:0042489","MONDO:0015356","MONDO:0000001"],"excluded_subClassOf":{"mondo":["MONDO:0008315"]},"has_material_basis_in_germline_mutation_in":{"http":["http://identifiers.org/hgnc/3393"]},"label":"prostate cancer/brain cancer susceptibility","mondo":"MONDO:0011361","parents":["MONDO:0015356"],"predisposes_towards":{"mondo":["MONDO:0001657"]},"synonym":{"exact":["prostate cancer/brain cancer susceptibility","prostate cancer/brain cancer susceptibility, somatic"],"related":["Capb","Pcbc"]},"xrefs":{"medgen":["400334"],"omim":["603688"],"umls":["C1863600"]}}},{"_id":"MONDO:0018502","_score":7.36427,"mondo":{"ancestors":["MONDO:0005070","MONDO:0021223","MONDO:0700096","MONDO:0001056","MONDO:0004992","MONDO:0021085","MONDO:0005626","MONDO:0003847","MONDO:0004335","MONDO:0045024","MONDO:0002516","MONDO:0004950","MONDO:0004993","MONDO:0023370","MONDO:0004298","MONDO:0000001","MONDO:0006181"],"children":["MONDO:0006226","MONDO:0007648","MONDO:0017790","MONDO:0100256"],"definition":"Hereditary gastric cancer refers to the occurrence of gastric cancer in a familial context and is described as two or more cases of gastric cancer in first or second degree relatives with at least one case diagnosed before the age of 50. Familial clustering is observed in 10% of all cases of gastric cancer, and includes hereditary diffuse gastric cancer (early onset diffuse-type gastric cancer), gastric adenocarcinoma and proximal polyposis of the stomach and familial intestinal gastric cancer (familial clustering of intestinal type gastric adenocarcinoma). Hereditary gastric cancer can also occur in other hereditary cancer syndromes such as Lynch syndrome, Li-Fraumeni syndrome, familial adenomatous polyposis and juvenile polyposis syndrome. [Orphanet:423776]","descendants":["MONDO:0100256","MONDO:0017790","MONDO:0007648","MONDO:0006226"],"label":"hereditary gastric cancer","mondo":"MONDO:0018502","parents":["MONDO:0003847","MONDO:0004950"],"synonym":{"exact":["hereditary cancer of stomach","hereditary gastric cancer"]},"xrefs":{"gard":["21758"],"medgen":["1843054"],"orphanet":["423776"],"umls":["C5680075"]}}},{"_id":"MONDO:0001060","_score":7.269791,"disease_ontology":{"_license":"https://github.com/DiseaseOntology/HumanDiseaseOntology/blob/master/DO_LICENSE.txt","ancestors":["DOID:14566","DOID:5517","DOID:305","DOID:3119","DOID:0050686","DOID:10534","DOID:4","DOID:76","DOID:77","DOID:7","DOID:0050687","DOID:162","DOID:3717","DOID:299"],"children":[],"def":"","descendants":[],"doid":"DOID:10541","name":"microinvasive gastric cancer","parents":["DOID:3717"],"synonyms":{"exact":["early gastric cancer","Surface gastric cancer"]},"xrefs":{"ncit":"C27131","snomedct_us_2023_03_01":"276809004","umls_cui":"C0349530"}},"disgenet":{"_license":"https://creativecommons.org/licenses/by/4.0/","genes_related_to_disease":[{"DPI":0.885,"DSI":0.429,"EI":1.0,"YearFinal":2017,"YearInitial":2017,"gene_id":174,"gene_name":"AFP","pubmed":[29121872],"score":0.01,"source":"BEFREE"},{"DPI":0.962,"DSI":0.373,"EI":1.0,"YearFinal":2016,"YearInitial":2014,"gene_id":324,"gene_name":"APC","pubmed":[27514024,24272205],"score":0.02,"source":"BEFREE"},{"DPI":0.808,"DSI":0.502,"EI":1.0,"YearFinal":2017,"YearInitial":2017,"gene_id":387,"gene_name":"RHOA","pubmed":[28624843],"score":0.01,"source":"BEFREE"},{"DPI":0.923,"DSI":0.344,"EI":1.0,"YearFinal":2014,"YearInitial":2014,"gene_id":595,"gene_name":"CCND1","pubmed":[25202078],"score":0.01,"source":"BEFREE"},{"DPI":0.423,"DSI":0.666,"EI":1.0,"YearFinal":2017,"YearInitial":2017,"gene_id":618,"gene_name":"BCYRN1","pubmed":[29039538],"score":0.01,"source":"BEFREE"},{"DPI":0.731,"DSI":0.459,"EI":1.0,"YearFinal":2008,"YearInitial":2008,"gene_id":864,"gene_name":"RUNX3","pubmed":[18097595],"score":0.01,"source":"BEFREE"},{"DPI":0.962,"DSI":0.363,"EI":1.0,"YearFinal":2019,"YearInitial":2016,"gene_id":960,"gene_name":"CD44","pubmed":[27923017,30913874,25779358],"score":0.03,"source":"BEFREE"},{"DPI":0.808,"DSI":0.401,"EI":1.0,"YearFinal":2010,"YearInitial":2010,"gene_id":999,"gene_name":"CDH1","pubmed":[20063069],"score":0.01,"source":"BEFREE"},{"DPI":0.769,"DSI":0.458,"EI":1.0,"YearFinal":2019,"YearInitial":2019,"gene_id":1045,"gene_name":"CDX2","pubmed":[31354341],"score":0.01,"source":"BEFREE"},{"DPI":0.846,"DSI":0.42,"EI":1.0,"YearFinal":2018,"YearInitial":2017,"gene_id":1048,"gene_name":"CEACAM5","pubmed":[29121872,29742692],"score":0.02,"source":"BEFREE"},{"DPI":0.731,"DSI":0.494,"EI":1.0,"YearFinal":2018,"YearInitial":2017,"gene_id":1084,"gene_name":"CEACAM3","pubmed":[29121872,29742692],"score":0.02,"source":"BEFREE"},{"DPI":0.769,"DSI":0.494,"EI":1.0,"YearFinal":2018,"YearInitial":2017,"gene_id":1087,"gene_name":"CEACAM7","pubmed":[29121872,29742692],"score":0.02,"source":"BEFREE"},{"DPI":0.808,"DSI":0.446,"EI":1.0,"YearFinal":2017,"YearInitial":2017,"gene_id":1268,"gene_name":"CNR1","pubmed":[27271924],"score":0.01,"source":"BEFREE"},{"DPI":0.846,"DSI":0.4,"EI":1.0,"YearFinal":2018,"YearInitial":2018,"gene_id":1351,"gene_name":"COX8A","pubmed":[30128004],"score":0.01,"source":"BEFREE"},{"DPI":0.615,"DSI":0.558,"EI":1.0,"YearFinal":2012,"YearInitial":2012,"gene_id":1365,"gene_name":"CLDN3","pubmed":[22290341],"score":0.01,"source":"BEFREE"},{"DPI":0.808,"DSI":0.494,"EI":1.0,"YearFinal":2012,"YearInitial":2012,"gene_id":1366,"gene_name":"CLDN7","pubmed":[22290341],"score":0.01,"source":"BEFREE"},{"DPI":0.846,"DSI":0.488,"EI":1.0,"YearFinal":2018,"YearInitial":2018,"gene_id":1371,"gene_name":"CPOX","pubmed":[29425880],"score":0.01,"source":"BEFREE"},{"DPI":0.923,"DSI":0.328,"EI":1.0,"YearFinal":2005,"YearInitial":2005,"gene_id":1636,"gene_name":"ACE","pubmed":[16365022],"score":0.01,"source":"BEFREE"},{"DPI":0.885,"DSI":0.426,"EI":1.0,"YearFinal":2019,"YearInitial":2019,"gene_id":1666,"gene_name":"DECR1","pubmed":[31370714],"score":0.01,"source":"BEFREE"},{"DPI":0.885,"DSI":0.295,"EI":1.0,"YearFinal":2015,"YearInitial":2015,"gene_id":1956,"gene_name":"EGFR","pubmed":[25593477],"score":0.01,"source":"BEFREE"},{"DPI":0.923,"DSI":0.328,"EI":1.0,"YearFinal":2018,"YearInitial":2015,"gene_id":2064,"gene_name":"ERBB2","pubmed":[30120594,25593477],"score":0.02,"source":"BEFREE"},{"DPI":0.615,"DSI":0.656,"EI":1.0,"YearFinal":2019,"YearInitial":2017,"gene_id":2098,"gene_name":"ESD","pubmed":[31382963,30725253,28378078,30298447],"score":0.04,"source":"BEFREE"},{"DPI":0.692,"DSI":0.588,"EI":1.0,"YearFinal":2017,"YearInitial":2017,"gene_id":2168,"gene_name":"FABP1","pubmed":[27884752],"score":0.01,"source":"BEFREE"},{"DPI":0.846,"DSI":0.474,"EI":1.0,"YearFinal":2017,"YearInitial":2017,"gene_id":2194,"gene_name":"FASN","pubmed":[27884752],"score":0.01,"source":"BEFREE"},{"DPI":0.808,"DSI":0.485,"EI":1.0,"YearFinal":2017,"YearInitial":2017,"gene_id":2520,"gene_name":"GAST","pubmed":[28072871],"score":0.01,"source":"BEFREE"},{"DPI":0.808,"DSI":0.489,"EI":1.0,"YearFinal":2019,"YearInitial":2019,"gene_id":2744,"gene_name":"GLS","pubmed":[30485682],"score":0.01,"source":"BEFREE"},{"DPI":0.577,"DSI":0.686,"EI":1.0,"YearFinal":2017,"YearInitial":2017,"gene_id":3004,"gene_name":"GZMM","pubmed":[28977792],"score":0.01,"source":"BEFREE"},{"DPI":0.885,"DSI":0.374,"EI":1.0,"YearFinal":2017,"YearInitial":2017,"gene_id":3082,"gene_name":"HGF","pubmed":[28595915],"score":0.01,"source":"BEFREE"},{"DPI":0.769,"DSI":0.476,"EI":1.0,"YearFinal":2015,"YearInitial":2015,"gene_id":3490,"gene_name":"IGFBP7","pubmed":[26043748],"score":0.01,"source":"BEFREE"},{"DPI":0.923,"DSI":0.373,"EI":1.0,"YearFinal":2004,"YearInitial":2004,"gene_id":3557,"gene_name":"IL1RN","pubmed":[15570075],"score":0.01,"source":"BEFREE"},{"DPI":0.962,"DSI":0.248,"EI":1.0}]}}],"_note":"Response truncated for documentation purposes"}

疾病 - 代码片段


curl --location --request GET 'https://zylalabs.com/api/4424/diseases+information+api/5437/disease?q=cancer' --header 'Authorization: Bearer YOUR_API_KEY'

要使用此端点，您必须在参数中指定一个 Mondo ID。

例如：MONDO:0011361

您可以从疾病端点获取此 ID。



                                                                            
GET https://pr140-testing.zylalabs.com/api/4424/diseases+information+api/5439/disease+by+id
测试端点

API 示例响应

       
                                                                                                        
                                                                                                                                                                                                                                                                                                                                        {"_id":"MONDO:0011361","_version":1,"ctd":{"omim":"603688","pathway_related_to_disease":[{"inference_gene_symbol":"EPHB2","kegg_pathway_id":"hsa04360","pathway_name":"Axon guidance","source":"CTD"},{"inference_gene_symbol":"EPHB2","pathway_name":"Developmental Biology","react_pathway_id":"R-HSA-1266738","source":"CTD"},{"inference_gene_symbol":"EPHB2","pathway_name":"EPH-Ephrin signaling","react_pathway_id":"R-HSA-2682334","source":"CTD"},{"inference_gene_symbol":"EPHB2","pathway_name":"L1CAM interactions","react_pathway_id":"R-HSA-373760","source":"CTD"},{"inference_gene_symbol":"EPHB2","pathway_name":"EPHB-mediated forward signaling","react_pathway_id":"R-HSA-3928662","source":"CTD"},{"inference_gene_symbol":"EPHB2","pathway_name":"Ephrin signaling","react_pathway_id":"R-HSA-3928664","source":"CTD"},{"inference_gene_symbol":"EPHB2","pathway_name":"EPH-ephrin mediated repulsion of cells","react_pathway_id":"R-HSA-3928665","source":"CTD"},{"inference_gene_symbol":"EPHB2","pathway_name":"Axon guidance","react_pathway_id":"R-HSA-422475","source":"CTD"}]},"disgenet":{"_license":"https://creativecommons.org/licenses/by/4.0/","genes_related_to_disease":[{"DPI":0.846,"DSI":0.374,"gene_id":2048,"gene_name":"EPHB2","score":0.4,"source":"CLINVAR"},{"DPI":0.846,"DSI":0.374,"gene_id":2048,"gene_name":"EPHB2","score":0.4,"source":"CTD_human"}],"variants_related_to_disease":[{"DSI":1.0,"chrom":"1","pos":22907980,"rsid":"rs121912582","score":0.7,"source":"CLINVAR"},{"DPI":0.08,"DSI":0.882,"chrom":"1","pos":22913757,"rsid":"rs76826147","score":0.7,"source":"CLINVAR"}],"xrefs":{"disease_name":"PROSTATE CANCER/BRAIN CANCER SUSCEPTIBILITY (finding)","mondo":"MONDO:0011361","omim":"603688","umls":"C1863600"}},"hpo":{"disease_name":"Prostate cancer/brain cancer susceptibility","omim":"603688","phenotype_related_to_disease":[{"biocuration":{"date":"2013-01-14","name":"HPO:skoehler"},"evidence":"IEA","hpo_id":"HP:0100006","omim_refs":"OMIM:603688","original_disease_id":"OMIM:603688"},{"biocuration":{"date":"2013-01-09","name":"HPO:skoehler"},"evidence":"IEA","hpo_id":"HP:0012125","omim_refs":"OMIM:603688","original_disease_id":"OMIM:603688"}]},"mondo":{"ancestors":["MONDO:0003847","MONDO:0020573","MONDO:0023370","MONDO:0021058","MONDO:0700096","MONDO:0002254","MONDO:0045024","MONDO:0042489","MONDO:0015356","MONDO:0000001"],"excluded_subClassOf":{"mondo":["MONDO:0008315"]},"has_material_basis_in_germline_mutation_in":{"http":["http://identifiers.org/hgnc/3393"]},"label":"prostate cancer/brain cancer susceptibility","mondo":"MONDO:0011361","parents":["MONDO:0015356"],"predisposes_towards":{"mondo":["MONDO:0001657"]},"synonym":{"exact":["prostate cancer/brain cancer susceptibility","prostate cancer/brain cancer susceptibility, somatic"],"related":["Capb","Pcbc"]},"xrefs":{"medgen":["400334"],"omim":["603688"],"umls":["C1863600"]}}}

通过ID获取疾病 - 代码片段


curl --location --request GET 'https://zylalabs.com/api/4424/diseases+information+api/5439/disease+by+id&ID=Required' --header 'Authorization: Bearer YOUR_API_KEY'

API 访问密钥和身份验证

注册后，每个开发者都会被分配一个个人 API 访问密钥，这是一个唯一的字母和数字组合，用于访问我们的 API 端点。要使用 疾病信息 API 进行身份验证，只需在 Authorization 标头中包含您的 bearer token。
标头
标头 描述
授权 [必需] 应为 Bearer access_key. 订阅后，请查看上方的"您的 API 访问密钥"。

简单透明的定价

无长期承诺。随时升级、降级或取消。 免费试用包括最多 50 个请求。

🚀 企业版

起价
$ 10,000/年

  • 自定义数量
  • 自定义速率限制
  • 专业客户支持
  • 实时 API 监控
zeiss-logo amazon-logo zoom-logo decathlon-logo
预约通话

客户喜爱的功能

  • ✔︎ 仅支付成功请求
  • ✔︎ 7 天免费试用
  • ✔︎ 多语言支持
  • ✔︎ 一个 API 密钥，所有 API。
  • ✔︎ 直观的仪表板
  • ✔︎ 全面的错误处理
  • ✔︎ 开发者友好的文档
  • ✔︎ Postman 集成
  • ✔︎ 安全的 HTTPS 连接
  • ✔︎ 可靠的正常运行时间

疾病信息 API FAQs

疾病信息API提供关于各种疾病的结构化数据和信息，包括遗传因素、相关基因、临床表现和相关途径

Zyla提供了几乎所有编程语言的广泛集成方法。您可以根据需要使用这些代码与您的项目集成

有不同的计划以满足各种口味，包括对少量请求的免费试用，但您的速率是有限的以避免滥用服务

该API至关重要，因为它允许用户获取广泛疾病的详细和最新信息，包括遗传数据、相关基因、变异、临床数据和相关通路

要使用此API，用户必须指明一种疾病的名称

获取疾病端点返回与基因、遗传变异和临床表型相关的疾病列表 根据疾病ID获取端点提供关于特定疾病的详细信息，包括与该疾病相关的通路和基因相互作用

关键字段包括“_id”（疾病标识符）、“ctd”（与基因和通路相关的数据）、“omim”（人类孟德尔遗传在线ID）和“pathway_related_to_disease”（与疾病相关的通路列表）

响应数据以JSON格式结构化，顶级对象包含元数据（如“took”和“total”）以及一个“hits”数组，详述每种疾病的信息，包括相关基因和途径

获取疾病端点提供疾病名称、相关基因和遗传变异 通过ID获取疾病端点提供特定疾病的详细信息，包括通路、基因相互作用和临床数据

GET疾病端点需要疾病名称作为参数，而通过ID获取疾病端点则需要一个特定的Mondo ID 这些参数允许用户定制他们的信息查询

用户可以分析返回的数据，以识别与疾病相关的遗传因素，支持临床决策，并为疾病机制的研究提供信息。结构化格式便于集成到应用程序中

数据来源于可信的生物医学数据库，包括比较毒基因组数据库（CTD）和人类在线孟德尔遗传（OMIM），确保了高准确性和可靠性

如果API返回部分或空结果，用户应验证输入参数的准确性。此外，考虑使用更广泛的搜索词或检查替代病名以改善结果检索

一般常见问题

Zyla API Hub 就像一个大型 API 商店，您可以在一个地方找到数千个 API。我们还为所有 API 提供专门支持和实时监控。注册后，您可以选择要使用的 API。请记住，每个 API 都需要自己的订阅。但如果您订阅多个 API，您将为所有这些 API 使用相同的密钥，使事情变得更简单。
价格以 USD（美元）、EUR（欧元）、CAD（加元）、AUD（澳元）和 GBP（英镑）列出。我们接受所有主要的借记卡和信用卡。我们的支付系统使用最新的安全技术，由 Stripe 提供支持，Stripe 是世界上最可靠的支付公司之一。如果您在使用卡片付款时遇到任何问题，请通过 [email protected]

此外，如果您已经以这些货币中的任何一种（USD、EUR、CAD、AUD、GBP）拥有有效订阅，该货币将保留用于后续订阅。只要您没有任何有效订阅，您可以随时更改货币。
定价页面上显示的本地货币基于您 IP 地址的国家/地区，仅供参考。实际价格以 USD（美元）为单位。当您付款时，即使您在我们的网站上看到以本地货币显示的等值金额，您的卡片对账单上也会以美元显示费用。这意味着您不能直接使用本地货币付款。
有时，银行可能会因其欺诈保护设置而拒绝收费。我们建议您首先联系您的银行，检查他们是否阻止了我们的收费。此外，您可以访问账单门户并更改关联的卡片以进行付款。如果这些方法不起作用并且您需要进一步帮助，请通过 [email protected]
价格由月度或年度订阅决定，具体取决于所选计划。
API 调用根据成功请求从您的计划中扣除。每个计划都包含您每月可以进行的特定数量的调用。只有成功的调用（由状态 200 响应指示）才会计入您的总数。这确保失败或不完整的请求不会影响您的月度配额。
Zyla API Hub 采用月度订阅系统。您的计费周期将从您购买付费计划的那一天开始，并在下个月的同一日期续订。因此，如果您想避免未来的费用，请提前取消订阅。
要升级您当前的订阅计划，只需转到 API 的定价页面并选择您要升级到的计划。升级将立即生效，让您立即享受新计划的功能。请注意，您之前计划中的任何剩余调用都不会转移到新计划，因此在升级时请注意这一点。您将被收取新计划的全部金额。
要检查您本月剩余多少 API 调用，请参考响应标头中的 "X-Zyla-API-Calls-Monthly-Remaining" 字段。例如，如果您的计划允许每月 1,000 个请求，而您已使用 100 个，则响应标头中的此字段将显示 900 个剩余调用。
要查看您的计划允许的最大 API 请求数，请检查 "X-Zyla-RateLimit-Limit" 响应标头。例如，如果您的计划包括每月 1,000 个请求，此标头将显示 1,000。
"X-Zyla-RateLimit-Reset" 标头显示您的速率限制重置之前的秒数。这告诉您何时您的请求计数将重新开始。例如，如果它显示 3,600，则意味着还有 3,600 秒直到限制重置。
是的，您可以随时通过访问您的账户并在账单页面上选择取消选项来取消您的计划。请注意，升级、降级和取消会立即生效。此外，取消后，您将不再有权访问该服务，即使您的配额中还有剩余调用。
为了让您有机会在没有任何承诺的情况下体验我们的 API，我们提供 7 天免费试用，允许您免费进行最多 50 次 API 调用。此试用只能使用一次，因此我们建议将其应用于您最感兴趣的 API。虽然我们的大多数 API 都提供免费试用，但有些可能不提供。试用在 7 天后或您进行了 50 次请求后结束，以先发生者为准。如果您在试用期间达到 50 次请求限制，您需要"开始您的付费计划"以继续发出请求。您可以在个人资料中的订阅 -> 选择您订阅的 API -> 定价标签下找到"开始您的付费计划"按钮。或者，如果您在第 7 天之前不取消订阅，您的免费试用将结束，您的计划将自动计费，授予您访问计划中指定的所有 API 调用的权限。请记住这一点以避免不必要的费用。
7 天后，您将被收取试用期间订阅的计划的全额费用。因此，在试用期结束前取消很重要。因忘记及时取消而提出的退款请求不被接受。
当您订阅 API 免费试用时，您可以进行最多 50 次 API 调用。如果您希望超出此限制进行额外的 API 调用，API 将提示您执行"开始您的付费计划"。您可以在个人资料中的订阅 -> 选择您订阅的 API -> 定价标签下找到"开始您的付费计划"按钮。
付款订单在每月 20 日至 30 日之间处理。如果您在 20 日之前提交请求，您的付款将在此时间范围内处理。
您可以通过我们的聊天渠道联系我们以获得即时帮助。我们始终在线，时间为上午 8 点至下午 5 点（EST）。如果您在该时间之后联系我们，我们将尽快回复您。此外，您可以通过 [email protected]
开始免费试用
 服务级别
100%
 响应时间
364ms

类别:

健康与健身

标签:

相关 API

检索症状信息 API

检索症状信息 API
健康与健身 7 天免费试用

服务级别:

100%

响应时间:

728ms

症状数据检索 API

症状数据检索 API
健康与健身 7 天免费试用

服务级别:

100%

响应时间:

806ms

健康状况检查器 API

健康状况检查器 API
健康与健身 7 天免费试用

服务级别:

100%

响应时间:

635ms

CoronaTracker API

CoronaTracker API
健康与健身 7 天免费试用

服务级别:

100%

响应时间:

2,662ms

健康症状提取器 API

健康症状提取器 API
健康与健身 7 天免费试用

服务级别:

100%

响应时间:

1,407ms

症状分析获取器 API

症状分析获取器 API
健康与健身 7 天免费试用

服务级别:

100%

响应时间:

1,453ms

动物信息 API

动物信息 API
科学与教育 7 天免费试用

服务级别:

100%

响应时间:

458ms

检测皮肤病 API

检测皮肤病 API
健康与健身

服务级别:

100%

响应时间:

0ms

动物信息 API

动物信息 API
科学与教育 7 天免费试用

服务级别:

100%

响应时间:

827ms

症状检查器 API

症状检查器 API
健康与健身 7 天免费试用

服务级别:

100%

响应时间:

1,860ms

您可能还喜欢